Article

Insurers Forcing Patients to Pay More for Costly Specialty Drugs

prescription drugs

cancer

r

heumatoid arthritis

Thousands of patients in California and across the nation who take expensive every month for , and other ailments are facing sticker shock at the pharmacy.

Aetna

Until recently, most of these patients typically paid modest co-pays for the advanced drugs. But increasingly, Anthem Blue Cross, and other insurers are shifting more prescriptions to a new category requiring patients to shoulder a larger share of the drug's cost.

Read the full story: http://hcp.lv/KXEKBf

Source: Los Angeles Times

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Cathy Eng, MD, FACP, FASCO
Leigh Maria Ramos-Platt, MD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Molly Dean, MSW, Siftwell
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo